Please try another search
Bioasis Technologies Inc., a development stage biopharmaceutical company, engages in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. It is developing xB3, a platform technology for the transport of therapeutic agents across the blood-brain barrier (BBB); and the treatment of central nervous system disorders (CNS), including brain cancers, and metabolic and neurodegenerative diseases. The company’s in-house development programs develop symptomatic and disease-modifying treatments for brain metastases (xB3-001), glioblastoma (xB3-002), and neurodegenerative diseases (xB3-007). It has research collaborations with Aposense Limited to focus on the delivery of siRNA therapeutics for CNS disorders; Oxyrane UK Ltd. to focus on combining xB3 technology and Oxyrane’s OxyCAT platform to deliver an undisclosed enhanced enzyme replacement therapy into the brain; and Janssen Biotech, Inc. to research, develop, and commercialize novel products based on Bioasis’ xB3 platform. The company also has a research collaboration and license agreement with Neuramedy Co Ltd. to research, develop, and commercialize an xB3TM version of its antibody, Tomaralimab. Bioasis Technologies Inc. was incorporated in 2006 and is headquartered in New Haven, Connecticut.
Name | Age | Since | Title |
---|---|---|---|
John H. Krystal | - | 2017 | Chairman of Scientific Advisory Board |
Jack Hoppin | - | 2018 | Member of Scientific Advisory Board |
Mario David Saltarelli | 63 | 2018 | Independent Non-Executive Director |
John de Groot | - | 2019 | Member of Medical Oncology Advisory Board |
Deborah Ann Rathjen | 65 | 2017 | Executive Chairman, CEO & President |
Hope S. Rugo | - | 2019 | Member of Medical Oncology Advisory Board |
John Murray Hemeon | 58 | 2020 | Independent Director |
Sue O’Connor | - | 2018 | Member of Scientific Advisory board |
Javier Cortés | - | 2019 | Member of Medical Oncology Advisory Board |
David M. Wurzer | 65 | 2018 | Independent Lead Director |
John P. Wikswo | - | 2017 | Member of Scientific Advisory Board |
John E. Curran | - | 2018 | Independent Director |
Jeffrey L. Cummings | 74 | 2017 | Member of Scientific Advisory Board |
May Orfali | 55 | 2020 | Member of Medical Oncology Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review